Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression

Molecular and Cellular Endocrinology

Volumn 315, Issue 1-2, 2010, Pages 188-194

  He, Ming ^a,b,c   Zhang, Lin ^c   Shao, Ying ^a   Xue, Hong ^a   Zhou, Li ^a   Wang, Xiao Fang ^b   Yu, Chen ^d   Yao, Tai ^a   Lu, Li Min ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiotensin II; High glucose; Mesangial cell; Renin prorenin receptor

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; GLUCOSE; LOSARTAN; MESSENGER RNA; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PRORENIN RECEPTOR; RENIN; STREPTOZOCIN;

ANGIOTENSIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION REGULATION; GLUCOSE INTAKE; HYPERGLYCEMIA; KIDNEY; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLUCOSE; HUMANS; KIDNEY; MALE; MESANGIAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, CELL SURFACE; RENIN; RNA, MESSENGER;

EID: 71849113401     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.10.008     Document Type: Article

References (20)

1. Bader M., and Ganten D. Update on tissue renin-angiotensin systems. J. Mol. Med. 86 (2008) 615-621
2. Border W.A., and Noble N.A. Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases. Semin. Nephrol. 21 (2001) 563-572
3. Danser A.H.J., Batenburg W.W., and van Esch J.H. Prorenin and the (pro)renin receptor-an update. Nephro. Dial. Transplant. 22 (2007) 1288-1292
4. Deinum J., Ronn B., Mathiesen E., Derkx F.H., Hop W.C., and Schalekamp M.A. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia 42 (1999) 1006-1010
5. He M., Zhang L., Shao Y., Wang X., Huang Y., Yao T., and Lu L. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur. J. Pharmacol. 606 (2009) 155-161
6. He M., Huang Y.L., Zhang L., Yao T., and Lu L.M. Expression of renin/prorenin receptor in rat kidney and mesangial cells. Acta Physiol. Sin. 59 (2007) 796-804
7. Huang Y., Noble N.A., Zhang J., Xu C., and Border W.A. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 72 (2007) 45-52
8. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., and Border W. Renin increases mesangial cell transforming growth factor-beta 1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 69 (2006) 105-113
9. Ichihara A., Hayashi K., Kaneshiro Y., Susuki F., Nakagawa T., Tada Y., Koura Y., Nishiyama A., Okada H., Uddin M.N., Nabi A.H.M.N., Ishida Y., Inagami T., and Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J. Clin. Invest. 114 (2004) 1128-1135
10. Liu X.G., Daim L., Yang C., Zhao Z.H., Zhang X.R., Zhang Z.G., and Guo M.Y. Study on the signalling pathway of inhibitory effect of adrenomedullin on the growth of cultured glomerular mesangial cells. Chin. Med. J. 118 (2005) 1374-1379
11. Luetscher J.A., Kraemer F.B., Wilson D.M., Schwartz H.C., and Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. N. Engl. J. Med. 312 (1985) 1412-1417
12. Nguyen G. The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology. Curr. Opin. Nephrol. Hypertens. 16 (2007) 129-133
13. Nguyen G., Burckle C., and Sraer J.D. The renin receptor: the facts, the promise and the hope. Curr. Opin. Nephrol. Hypertens. (2003)
14. Nguyen G., Delarue F., Berrou J., Rondeau E., and Sraer J.D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 50 (1996) 1897-1903
15. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109 (2002) 1417-1427
16. Nussberger J., Wuerzner G., Jensen C., and Brunner H.R. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension 39 (2002) e1-e8
17. Paul M., Poyan, Mehr A., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 86 (2006) 747-803
18. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R., Pandolfi P.P., Ruiz P., Unger T., and Funke-Kaiser H. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcriptor factor PLZF. Circ. Res. 99 (2006) 1355-1366
19. Schmittgen T.D., Zakrajsek B.A., Mills A.G., Gorn V., Singer M.J., and Reed M.W. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and realtime methods. Anal. Biochem. 285 (2000) 194-204
20. Senbonmatsu T., Saito T., Landon E.J., Watanabe O., Price Jr. E., Roberts R.L., Imboden H., Fitzgerald T.G., Gaffney F.A., and Inagami T. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J. 22 (2003) 6471-6482